AllerGenis
PrivateLast Round
Crowdfunding
Apr 24, 2023
Est. Valuation
$40M
Company Overview
AllerGenis operates in Healthcare & Life Sciences and is based in Hatfield, Pennsylvania. Its latest recorded funding round was a Crowdfunding round in April 2023.
AllerGenis is a biotechnology company that provides data-driven precision diagnostic services for food allergies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AllerGenis Comparables
Compare AllerGenis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spiriplex, Inc. | 80% | |
| ATANIS Biotech AG | 78% | |
| MacroArray Diagnostics GmbH | 77% |
For institutional investors. Book with your work email.
AllerGenis Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AllerGenis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartEngine Crowdfunding | Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 10, 2025
Monthly visitors grew 45% MoM, reaching 1K.
- Oct 29, 2024
Monthly visitors grew 291% MoM, reaching 2K.
For institutional investors. Book with your work email.
AllerGenis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AllerGenis's valuation, stock price, and market status.
Is AllerGenis a public or private company?
AllerGenis is a private company.
What is the current stock price of AllerGenis?
AllerGenis is a private company, so its shares have no public market price. Caplight tracks AllerGenis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AllerGenis worth (valuation)?
AllerGenis's valuation is estimated at $40.0M based on funding round data.
Can I buy AllerGenis stock?
AllerGenis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AllerGenis's last funding round?
AllerGenis's most recent funding round was Crowdfunding on April 24, 2023.
Who are the main investors in AllerGenis?
Key investors in AllerGenis include StartEngine Crowdfunding.
Will AllerGenis IPO soon?
No public IPO plans have been announced for AllerGenis.
How can I track AllerGenis secondary market activity?
Caplight tracks bids, offers, and trades in AllerGenis's shares on secondary markets.